|Articles|November 15, 2002
HRT in Trouble
San Francisco - Despite the unexpected finding that combined use of oral conjugated equine estrogens (CEE) and oral medroxyprogesterone acetate (MPA) actually raises a healthy menopausal women's risk of coronary heart disease, and that it increases invasive breast cancer risk, gynecologist Susan Ballagh, M.D., remains a proponent of the popular regimen for appropriate patients.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Medicus Pharma Completes Phase 2 Enrollment of D-MNA Study to Non-Invasively Treat BCC
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Phase 2 Nemolizumab Trial Opens for CPUO
4
Balancing Pathophysiology and Patient Lifestyle in Acne Management: Part 1
5














